Apyx Working Capital vs Enterprise Value Analysis

APYX Stock

USD 1.50 0.18 13.64%

Apyx Medical financial indicator trend analysis is way more than just evaluating Apyx Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Apyx Medical is a good investment. Please check the relationship between Apyx Medical Working Capital and its Enterprise Value accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Working Capital vs Enterprise Value

Working Capital vs Enterprise Value Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Apyx Medical Working Capital account and Enterprise Value. At this time, the significance of the direction appears to have no relationship.

The correlation between Apyx Medical's Working Capital and Enterprise Value is 0.0. Overlapping area represents the amount of variation of Working Capital that can explain the historical movement of Enterprise Value in the same time period over historical financial statements of Apyx Medical, assuming nothing else is changed. The correlation between historical values of Apyx Medical's Working Capital and Enterprise Value is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Working Capital of Apyx Medical are associated (or correlated) with its Enterprise Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Enterprise Value has no effect on the direction of Working Capital i.e., Apyx Medical's Working Capital and Enterprise Value go up and down completely randomly.

Correlation Coefficient

0.0

Relationship Direction	Flat
Relationship Strength	Insignificant

View All Relationships

Working Capital

The difference between a company’s current assets and current liabilities, indicating the liquidity and operational efficiency of the business.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Apyx Medical theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Apyx Medical debt, but would also pocket its cash. Enterprise Value is more accurate representation of Apyx Medical value than its market capitalization because it takes into account all of Apyx Medical existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Most indicators from Apyx Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Apyx Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.At this time, Apyx Medical's Selling General Administrative is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 88.8 M in 2024, despite the fact that Tax Provision is likely to grow to (2.2 M).

	2021	2022	2023	2024 (projected)
Gross Profit	33.6M	29.1M	14.1M	12.4M
Total Revenue	48.5M	44.5M	52.3M	26.2M

Gross Profit Total Revenue

Apyx Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Total Assets		0.39	0.54	0.82	0.81	0.32	0.19	-0.6	0.15	0.67	0.82	-0.11	0.41	0.94	0.66	-0.45	-0.05	0.74	0.32	0.11	0.77	0.78	0.5	0.4	1.0	0.54
Short Long Term Debt Total	0.39		0.71	0.46	-0.2	-0.04	-0.44	0.25	-0.68	0.55	0.48	0.04	0.75	0.28	0.3	-0.2	-0.16	0.06	0.97	0.19	0.41	0.56	0.96	0.29	0.37	0.09
Other Current Liab	0.54	0.71		0.65	0.11	-0.02	-0.21	0.17	-0.55	0.7	0.35	-0.23	0.54	0.43	0.48	-0.22	0.09	0.42	0.66	0.32	0.44	0.79	0.74	0.23	0.55	0.16
Total Current Liabilities	0.82	0.46	0.65		0.53	0.23	0.09	-0.54	-0.27	0.95	0.82	-0.23	0.58	0.66	0.89	-0.31	0.14	0.71	0.4	0.21	0.85	0.88	0.62	0.36	0.83	0.33
Total Stockholder Equity	0.81	-0.2	0.11	0.53		0.33	0.43	-0.77	0.63	0.29	0.55	-0.14	-0.06	0.84	0.45	-0.31	0.06	0.73	-0.29	-0.02	0.52	0.44	-0.1	0.23	0.82	0.56
Property Plant And Equipment Net	0.32	-0.04	-0.02	0.23	0.33		0.25	-0.32	0.0	0.26	0.26	0.76	0.28	0.13	0.3	-0.7	-0.75	0.61	0.0	0.71	0.37	0.39	0.07	0.88	0.25	0.24
Current Deferred Revenue	0.19	-0.44	-0.21	0.09	0.43	0.25		-0.51	0.35	0.03	0.15	-0.14	-0.55	0.29	0.0	-0.26	-0.03	0.49	-0.39	-0.27	-0.12	0.14	-0.31	0.06	0.21	0.17
Net Debt	-0.6	0.25	0.17	-0.54	-0.77	-0.32	-0.51		-0.46	-0.35	-0.73	0.17	0.09	-0.6	-0.48	0.19	-0.16	-0.6	0.3	0.22	-0.63	-0.32	0.11	-0.18	-0.61	-0.41
Retained Earnings	0.15	-0.68	-0.55	-0.27	0.63	0.0	0.35	-0.46		-0.49	-0.07	-0.1	-0.59	0.34	-0.27	0.08	0.09	0.04	-0.71	-0.36	-0.11	-0.41	-0.68	-0.23	0.16	0.34
Accounts Payable	0.67	0.55	0.7	0.95	0.29	0.26	0.03	-0.35	-0.49		0.7	-0.13	0.64	0.47	0.82	-0.35	0.04	0.61	0.52	0.34	0.77	0.87	0.71	0.4	0.67	0.25
Cash	0.82	0.48	0.35	0.82	0.55	0.26	0.15	-0.73	-0.07	0.7		-0.12	0.45	0.74	0.65	-0.32	0.03	0.58	0.42	-0.06	0.85	0.69	0.58	0.37	0.82	0.43
Non Current Assets Total	-0.11	0.04	-0.23	-0.23	-0.14	0.76	-0.14	0.17	-0.1	-0.13	-0.12		0.3	-0.28	-0.12	-0.6	-0.91	0.04	0.11	0.68	-0.04	-0.01	0.03	0.64	-0.2	-0.1
Non Currrent Assets Other	0.41	0.75	0.54	0.58	-0.06	0.28	-0.55	0.09	-0.59	0.64	0.45	0.3		0.15	0.65	-0.35	-0.3	0.2	0.72	0.52	0.62	0.6	0.78	0.48	0.37	0.04
Cash And Short Term Investments	0.94	0.28	0.43	0.66	0.84	0.13	0.29	-0.6	0.34	0.47	0.74	-0.28	0.15		0.42	-0.28	0.08	0.62	0.21	-0.14	0.61	0.59	0.36	0.21	0.95	0.58
Net Receivables	0.66	0.3	0.48	0.89	0.45	0.3	0.0	-0.48	-0.27	0.82	0.65	-0.12	0.65	0.42		-0.3	0.11	0.66	0.24	0.28	0.78	0.79	0.45	0.36	0.66	0.19
Good Will	-0.45	-0.2	-0.22	-0.31	-0.31	-0.7	-0.26	0.19	0.08	-0.35	-0.32	-0.6	-0.35	-0.28	-0.3		0.78	-0.47	-0.23	-0.42	-0.32	-0.55	-0.28	-0.49	-0.38	-0.2
Common Stock Total Equity	-0.05	-0.16	0.09	0.14	0.06	-0.75	-0.03	-0.16	0.09	0.04	0.03	-0.91	-0.3	0.08	0.11	0.78		-0.09	-0.25	-0.55	0.0	-0.11	-0.18	-0.61	0.03	-0.06
Common Stock Shares Outstanding	0.74	0.06	0.42	0.71	0.73	0.61	0.49	-0.6	0.04	0.61	0.58	0.04	0.2	0.62	0.66	-0.47	-0.09		-0.01	0.38	0.57	0.8	0.19	0.62	0.73	0.4
Non Current Liabilities Total	0.32	0.97	0.66	0.4	-0.29	0.0	-0.39	0.3	-0.71	0.52	0.42	0.11	0.72	0.21	0.24	-0.23	-0.25	-0.01		0.2	0.35	0.5	0.97	0.31	0.3	0.0
Inventory	0.11	0.19	0.32	0.21	-0.02	0.71	-0.27	0.22	-0.36	0.34	-0.06	0.68	0.52	-0.14	0.28	-0.42	-0.55	0.38	0.2		0.22	0.38	0.23	0.76	0.05	0.01
Other Current Assets	0.77	0.41	0.44	0.85	0.52	0.37	-0.12	-0.63	-0.11	0.77	0.85	-0.04	0.62	0.61	0.78	-0.32	0.0	0.57	0.35	0.22		0.68	0.53	0.44	0.76	0.47
Other Stockholder Equity	0.78	0.56	0.79	0.88	0.44	0.39	0.14	-0.32	-0.41	0.87	0.69	-0.01	0.6	0.59	0.79	-0.55	-0.11	0.8	0.5	0.38	0.68		0.67	0.51	0.77	0.27
Total Liab	0.5	0.96	0.74	0.62	-0.1	0.07	-0.31	0.11	-0.68	0.71	0.58	0.03	0.78	0.36	0.45	-0.28	-0.18	0.19	0.97	0.23	0.53	0.67		0.37	0.48	0.09
Property Plant And Equipment Gross	0.4	0.29	0.23	0.36	0.23	0.88	0.06	-0.18	-0.23	0.4	0.37	0.64	0.48	0.21	0.36	-0.49	-0.61	0.62	0.31	0.76	0.44	0.51	0.37		0.34	0.26
Total Current Assets	1.0	0.37	0.55	0.83	0.82	0.25	0.21	-0.61	0.16	0.67	0.82	-0.2	0.37	0.95	0.66	-0.38	0.03	0.73	0.3	0.05	0.76	0.77	0.48	0.34		0.54
Short Term Debt	0.54	0.09	0.16	0.33	0.56	0.24	0.17	-0.41	0.34	0.25	0.43	-0.1	0.04	0.58	0.19	-0.2	-0.06	0.4	0.0	0.01	0.47	0.27	0.09	0.26	0.54

Click cells to compare fundamentals

Apyx Medical Account Relationship Matchups

Apyx Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	84.7M	74.1M	68.7M	51.8M	79.2M	83.2M
Short Long Term Debt Total	1.1M	676K	305K	796K	38.5M	40.4M
Other Current Liab	1.5M	1.7M	1.9M	8.1M	9.2M	9.6M
Total Current Liabilities	12.2M	9.2M	13.2M	11.9M	12.7M	13.4M
Total Stockholder Equity	71.3M	63.7M	53.7M	37.6M	26.7M	24.4M
Property Plant And Equipment Net	7.6M	7.2M	6.9M	7.6M	7.1M	5.3M
Net Debt	(57.7M)	(41.2M)	(30.6M)	(9.4M)	(5.2M)	(5.4M)
Retained Earnings	14.5M	2.6M	(12.6M)	(35.7M)	(54.4M)	(51.7M)
Accounts Payable	2.4M	1.5M	2.6M	2.7M	2.7M	2.8M
Cash	58.8M	41.9M	30.9M	10.2M	43.7M	45.8M
Non Current Assets Total	8.0M	8.0M	8.0M	8.8M	8.9M	8.2M
Non Currrent Assets Other	391K	807K	1.1M	1.2M	1.7M	1.8M
Cash And Short Term Investments	58.8M	41.9M	30.9M	10.2M	43.7M	45.8M
Net Receivables	9.2M	17.3M	21.2M	18.2M	14.1M	14.8M
Common Stock Shares Outstanding	34.1M	34.2M	34.3M	34.5M	34.6M	22.4M
Liabilities And Stockholders Equity	84.7M	74.1M	68.7M	51.8M	79.2M	83.2M
Non Current Liabilities Total	1.2M	1.1M	1.5M	2.1M	39.6M	41.6M
Inventory	5.1M	4.1M	6.8M	11.8M	9.9M	5.3M
Other Current Assets	3.6M	2.8M	1.9M	2.7M	2.7M	2.9M
Other Stockholder Equity	56.7M	61.1M	66.2M	73.3M	81.1M	85.2M
Total Liab	13.4M	10.3M	14.7M	14.0M	52.3M	54.9M
Property Plant And Equipment Gross	7.5M	7.2M	6.9M	7.6M	10.7M	5.4M
Total Current Assets	76.7M	66.1M	60.7M	43.0M	70.4M	73.9M
Other Assets	191K	1.5M	1.1M	1.2M	1.4M	1.1M
Property Plant Equipment	6.6M	7.2M	6.6M	6.8M	7.8M	5.8M
Net Tangible Assets	71.3M	63.7M	53.7M	37.6M	43.2M	40.5M
Retained Earnings Total Equity	14.5M	2.6M	(12.6M)	(35.7M)	(41.1M)	(39.0M)
Capital Surpluse	56.7M	61.1M	66.2M	73.3M	84.3M	51.5M

Pair Trading with Apyx Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Apyx Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apyx Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against Apyx Stock

0.88	DSGN	Design Therapeutics Financial Report 14th of May 2024	Pair Corr
0.82	AGTI	Agiliti Financial Report 14th of May 2024	Pair Corr
0.75	ELEV	Elevation Oncology Earnings Call This Week	Pair Corr
0.69	VKTX	Viking Therapeutics Potential Growth	Pair Corr
0.66	NXL	Nexalin Technology	Pair Corr

The ability to find closely correlated positions to Apyx Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Apyx Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Apyx Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Apyx Medical to buy it.

The correlation of Apyx Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Apyx Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Apyx Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Apyx Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Apyx Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Apyx Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Apyx Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Apyx Medical Stock:

How To Invest In Apyx

Details

Is Apyx Stock a good investment?

Details

What is Apyx Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Apyx Stock analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.

	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences

Is Apyx Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apyx Medical. If investors know Apyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apyx Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.54)

Revenue Per Share

1.512

Quarterly Revenue Growth

0.163

Return On Assets

(0.19)

Return On Equity

(0.58)

The market value of Apyx Medical is measured differently than its book value, which is the value of Apyx that is recorded on the company's balance sheet. Investors also form their own opinion of Apyx Medical's value that differs from its market value or its book value, called intrinsic value, which is Apyx Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apyx Medical's market value can be influenced by many factors that don't directly affect Apyx Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Apyx Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Apyx Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apyx Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Apyx Working Capital vs Enterprise Value Analysis

Working Capital vs Enterprise Value

Working Capital vs Enterprise Value Correlation Analysis

Correlation Coefficient

Working Capital

Enterprise Value

Apyx Medical fundamental ratios Correlations

Apyx Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Apyx Medical fundamental ratios Accounts

Pair Trading with Apyx Medical

Moving against Apyx Stock

Complementary Tools for Apyx Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Non Current Liabilities Total	+ 0.97	Short Long Term Debt Total
Total Liab	+ 0.97	Non Current Liabilities Total
Total Liab	+ 0.96	Short Long Term Debt Total
Accounts Payable	+ 0.95	Total Current Liabilities
Total Current Assets	+ 0.95	Cash And Short Term Investments

Common Stock Total Equity	- 0.91	Non Current Assets Total
Net Debt	- 0.77	Total Stockholder Equity
Common Stock Total Equity	- 0.75	Property Plant And Equipment Net
Cash	- 0.73	Net Debt
Non Current Liabilities Total	- 0.71	Retained Earnings
Good Will	- 0.7	Property Plant And Equipment Net